Chemical identity
Des-6-[4-(2-hydroxyethyl)-1-piperazinyl]-6-chloro Dasatinib
CAS 910297-71-1 · C16H13Cl2N5O2S
01Identity
Identifiers and names for this exact compound. Empty fields are left unassigned.
| Lazychem ID | LC-12043 |
|---|---|
| PubChem CID | 25022897 |
| Name | Des-6-[4-(2-hydroxyethyl)-1-piperazinyl]-6-chloro Dasatinib |
| CAS RN | 910297-71-1 |
| Molecular formula | C16H13Cl2N5O2S |
| Molecular weight | 410.27 g/mol |
| IUPAC name | N-[2-Chloro-6-(hydroxymethyl)phenyl]-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide |
| InChIKey | IFQFVJBGDUJCSG-UHFFFAOYSA-N |
02Structure identifiers
![2D structure: Des-6-[4-(2-hydroxyethyl)-1-piperazinyl]-6-chloro Dasatinib, CAS 910297-71-1](/structures/pubchem/25022897/910297-71-1-des-6-4-2-hydroxyethyl-1-piperazinyl-6-chloro-dasatinib-2d-structure-900.png)
Structure facts for this exact identity.
| Molecular formula | C16H13Cl2N5O2S |
|---|---|
| InChIKey | IFQFVJBGDUJCSG-UHFFFAOYSA-N |
| Ring count | 3 |
| Defined stereocentres | 0 |
| Unassigned stereocentres | 0 |
| SMILES | CC1=NC(=CC(=N1)Cl)NC2=NC=C(S2)C(=O)NC3=C(C=CC=C3Cl)CO |
|---|---|
| InChI | InChI=1S/C16H13Cl2N5O2S/c1-8-20-12(18)5-13(21-8)22-16-19-6-11(26-16)15(25)23-14-9(7-24)3-2-4-10(14)17/h2-6,24H,7H2,1H3,(H,23,25)(H,19,20,21,22) |
03Possible N-nitroso structures
A record-level structural review indicates a possible N-nitroso candidate. This is not a confirmed impurity, formation prediction or analytical finding.
A structural result alone does not establish that a nitrosamine forms. A process-specific and analytical assessment is required.
04India status for this compound
These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.
| NDPS / RCS | NOT FOUND IN REVIEWED ENTRIES | CAS 910297-71-1 was not found in the reviewed exact-identity entries. Generic, class, analogue, salt and isomer provisions were not evaluated. |
|---|---|---|
| SCOMET | NOT FOUND IN REVIEWED CAS ENTRIES | CAS 910297-71-1 was not found in the reviewed exact-CAS mapping. Generic and analogue entries were not evaluated. |
- Narcotic Drugs and Psychotropic Substances Act, 1985, ScheduleDepartment of Revenue, Government of India · source version 1985-09-16
- Controlled-substances notifications and amendmentsDepartment of Revenue, Government of India · source version 2026-03-11
- Appendix 3, SCOMET ListDirectorate General of Foreign Trade, Government of India · source version 2024-09-02
05Names and relationships
Associated parent compound
Dasatinib
View API and impurity familyOther names
- Dasatinib Impurity 13
- N-[2-chloro-6-(hydroxymethyl)phenyl]-2-[(6-chloro-2-methylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide
- IFQFVJBGDUJCSG-UHFFFAOYSA-N
- 2-((6-Chloro-2-methylpyrimidin-4-yl)amino)-N-(2-chloro-6-(hydroxymethyl)phenyl)thiazole-5-carboxamide
- 2-[(6-chloro-2-methylpyrimidin-4-yl)amino]-N-[2-chloro-6-(hydroxymethyl)phenyl]-1,3-thiazole-5-carboxamide
- 5-Thiazolecarboxamide, N-[2-chloro-6-(hydroxymethyl)phenyl]-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-
06Documented history
Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.
No verified discovery, first report, occurrence, use or issue event is currently available for this identity.
07Sources
- S01PubChem compound record, CID 25022897
Names and machine-readable chemical identity properties.
- S02NCBI website and molecular data policies
Reuse policy for NCBI molecular data. This page does not reproduce vendor descriptions or contributed narrative text.
- S03Narcotic Drugs and Psychotropic Substances Act, 1985, Schedule
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S04Controlled-substances notifications and amendments
Department of Revenue, Government of India. Used for the exact-compound India status shown on this page.
- S05Appendix 3, SCOMET List
Directorate General of Foreign Trade, Government of India. Used for the exact-compound India status shown on this page.
